Sarepta Therapeutics, SRPT
Jump To Section
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
Sarepta Therapeutics, (SRPT) Business Model and Operations Summary
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
Key Insights
Sarepta Therapeutics, (SRPT) Core Market Data and Business Metrics
Latest Closing Price
$15.91Market Cap
$1.56 BillionPrice-Earnings Ratio
-6.05Total Outstanding Shares
98.28 Million SharesTotal Employees
1,372Current Dividend
No dividendIPO Date
June 4, 1997SIC Description
Pharmaceutical PreparationsHeadquarters
215 First Street, Cambridge, MA, 02142